Why HIV vaccine research is now about much more than HIV

The press release, issued earlier this year, announced a partnership that surely raised a few eyebrows. The International AIDS Vaccine Initiative would be working with a coalition on epidemic preparedness to develop a Lassa fever vaccine.

Then, earlier this month, IAVI, as the HIV vaccine group is known, announced it would absorb the operations of an organization founded to spur development of better tuberculosis vaccines.

What was a nonprofit group created to spearhead work on HIV vaccines doing dabbling in Lassa fever and tuberculosis?

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In